BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN
BEGIN:VTIMEZONE
TZID:Eastern Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Eastern Standard Time
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Eastern Daylight Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:CEUs: 2Course Description:Beginning in June 2023\, dentists wil
 l be required to check a box on their online DEA registration form – regar
 dless of whether a registrant is completing their initial registration app
 lication or renewing their registration – affirming that they have complet
 ed a new one time eight-hour training requirement. The deadline for satisf
 ying the requirement is the date of a practitioners’ next scheduled DEA re
 gistration submission on or after June 27\, 2023. This present course prov
 ides two of the eight hours of the requirement.Learning Objectives:After c
 ompleting the course\, the participants will be able to:Describe the ratio
 nale for using opiate medications in opioid withdrawal.Name the three majo
 r drugs used to treat opioid use disorder.For the drugs named above\, desc
 ribe its mechanism of action\, key adverse effects and drug formulations.D
 escribe the role of naloxone in the buprenorphine formulation (Suboxone).D
 escribe the requirements for physicians to prescribe Suboxone in Office-ba
 sed Opioid Treatment (OBOT). Also\, the latest methadone/buprenorphine rul
 e as of April 2024.List ten symptoms of opiate withdrawal.Speaker:Richard 
 Wynn\, PhDRegister Here
DTEND:20250605T010000Z
DTSTAMP:20260613T222449Z
DTSTART:20250604T230000Z
LOCATION:
SEQUENCE:0
SUMMARY:Drugs Approved for Treatment of a Substance Use Disorders
UID:RFCALITEM639169862893077310
X-ALT-DESC;FMTTYPE=text/html:<div data-block="true" data-editor="3loj0" dat
 a-offset-key="al0o8-0-0"><div data-offset-key="al0o8-0-0"><div data-block=
 "true" data-editor="3loj0" data-offset-key="8d7av-0-0"><div data-offset-ke
 y="8d7av-0-0"><p>CEUs:&nbsp\;2</p></div></div><div data-block="true" data-
 editor="3loj0" data-offset-key="khlp-0-0"><div data-offset-key="khlp-0-0">
 </div></div><p>Course Description:<br>Beginning in June 2023\, dentists wi
 ll be required to check a box on their online DEA registration form – rega
 rdless of whether a registrant is completing their initial registration ap
 plication or renewing their registration – affirming that they have comple
 ted a new one time eight-hour training requirement. The deadline for satis
 fying the requirement is the date of a practitioners’ next scheduled DEA r
 egistration submission on or after June 27\, 2023. This present course pro
 vides two of the eight hours of the requirement.</p></div></div><div data-
 block="true" data-editor="3loj0" data-offset-key="emv7p-0-0"><div data-off
 set-key="emv7p-0-0">Learning Objectives:</div></div><div data-block="true"
  data-editor="6p61o" data-offset-key="18uai-0-0"><div data-offset-key="18u
 ai-0-0">After completing the course\, the participants will be able to:</d
 iv></div><ul data-offset-key="538j0-0-0"><li data-block="true" data-editor
 ="6p61o" data-offset-key="538j0-0-0"><div data-offset-key="538j0-0-0">Desc
 ribe the rationale for using opiate medications in opioid withdrawal.</div
 ></li><li data-block="true" data-editor="6p61o" data-offset-key="2g9lr-0-0
 "><div data-offset-key="2g9lr-0-0">Name the three major drugs used to trea
 t opioid use disorder.</div></li><li data-block="true" data-editor="6p61o"
  data-offset-key="a9i53-0-0"><div data-offset-key="a9i53-0-0">For the drug
 s named above\, describe its mechanism of action\, key adverse effects and
  drug formulations.</div></li><li data-block="true" data-editor="6p61o" da
 ta-offset-key="3mlvv-0-0"><div data-offset-key="3mlvv-0-0">Describe the ro
 le of naloxone in the buprenorphine formulation (Suboxone).</div></li><li 
 data-block="true" data-editor="6p61o" data-offset-key="12ilu-0-0"><div dat
 a-offset-key="12ilu-0-0">Describe the requirements for physicians to presc
 ribe Suboxone in Office-based Opioid Treatment (OBOT). Also\, the latest m
 ethadone/buprenorphine rule as of April 2024.</div></li><li data-block="tr
 ue" data-editor="6p61o" data-offset-key="dh4qj-0-0"><div data-offset-key="
 dh4qj-0-0">List ten symptoms of opiate withdrawal.</div></li></ul><div dat
 a-block="true" data-editor="3loj0" data-offset-key="5dck9-0-0"><div data-o
 ffset-key="5dck9-0-0">Speaker:</div></div><div data-block="true" data-edit
 or="3loj0" data-offset-key="khlp-0-0"><div data-offset-key="khlp-0-0"><p>R
 ichard Wynn\, PhD</p><p><a href="https://web.cvent.com/event/01bbf5f0-e3a3
 -4c82-9df4-dd77eddaf9f1/summary">Register Here</a></p></div></div>
END:VEVENT
END:VCALENDAR